Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-Year results of a randomized trial and study of incretin effect

Obesity Surgery

Volumn 24, Issue 9, 2014, Pages 1552-1562

  Lee, Wei Jei ^a   Chong, Keong ^a   Lin, Yu Hung ^b   Wei, Jih Hua ^a   Chen, Shu Chun ^a  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Gastric bypass; Incretin effect; Randomized trial; Sleeve gastrectomy; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INCRETIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; LAPAROSCOPIC SLEEVE GASTRECTOMY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE ANASTOMOSIS GASTRIC BYPASS; SLEEVE GASTRECTOMY; STOMACH BYPASS; WEIGHT REDUCTION; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LAPAROSCOPY; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PILOT STUDY; PROCEDURES; SECRETION (PROCESS); TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY; PILOT PROJECTS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84906264808     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1344-5     Document Type: Article

References (45)

1. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA: J Am Med Assoc. 2004;292(14):1724-37. doi:10.1001/jama.292.14.1724.
2. Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg. 2004;139(10):1088-92. doi:10.1001/archsurg.139. 10.1088.
3. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-93. doi:10.1056/NEJMoa035622.
4. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-52. doi:10.1056/NEJMoa066254.
5. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA: J Am Med Assoc. 2012;307(1):56-65. doi:10.1001/jama.2011.1914.
6. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-56. doi:10.1016/j.amjmed.2008.09.041.
7. Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med: J B Diabet Assoc. 2011;28(6):628-42.
8. Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005;15(6):751-7. doi:10.1381/0960892054222614.
9. Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2008;12(5):945-52. doi:10.1007/s11605-007-0319-4.
10. Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399-405.
11. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741-9. doi:10.1097/01.sla.0000224726.61448.1b.
12. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1-11. doi:10.1097/01.sla.0000102989.54824.fc.
13. Zervos EE, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg. 2010;210(5):564-72. doi:10.1016/j.jamcollsurg.2009.12.025.
14. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251(2):236-43. doi:10.1097/SLA. 0b013e3181bdfbff.
15. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143-8. doi:10.1001/archsurg.2010.326.
16. Lee WJ, Chen CY, Chong K, et al. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2011;7(6):683-90. doi:10.1016/j.soard.2011.07.009.
17. Chen CY, Lee WJ, Asakawa A, et al. Insulin secretion and interleukin-1beta dependent mechanisms in human diabetes remission after metabolic surgery. Curr Med Chem. 2013;20(18):2374-88.
18. Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20-8.
19. Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15(5):648-54. doi:10.1381/0960892053923752.
20. Ser KH, Lee WJ, Lee YC, et al. Experience in laparoscopic sleeve gastrectomy formorbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage. Surg Endosc. 2010;24(9):2253-9. doi:10.1007/s00464-010- 0945-x.
21. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA: J Am Med Assoc. 2001;285(19):2486-97.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
23. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585-98.
24. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA: J Am Med Assoc. 2013;309(21):2240-9. doi:10.1001/jama.2013.5835.
25. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes. N Engl J Med. 0(0):null. doi:10.1056/NEJMoa1401329.
26. Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg. 2011;21(7):889-95. doi:10.1007/s11695-011-0401-6.
27. Lebovitz HE. Metabolic surgery for type 2 diabetes with BMI <35 kg/m(2): an endocrinologist 's perspective. Obes Surg. 2013;23(6):800-8. doi:10.1007/s11695-013-0907-1.
28. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA: J Am Med Assoc. 2013;309(21):2250-61. doi:10.1001/jama.2013.4851.
29. Yang X, So WY, Kong AP, et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol. 2008;101(5):596-601. doi:10.1016/j.amjcard.2007.10.019.
30. Jimenez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256(6):1023-9. doi:10.1097/SLA. 0b013e318262ee6b.
31. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401-7. doi:10.1097/SLA. 0b013e318156f012.
32. Peterli R, Borbely Y, Kern B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690-4. doi:10.1097/SLA.0b013e3182a67426.
33. Yang X, Yang G, Wang W, et al. A meta-analysis: to compare the clinical results between gastric bypass and sleeve gastrectomy for the obese patients. Obes Surg. 2013;23(7):1001-10. doi:10.1007/s11695-013-0938-7.
34. Laferrere B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30(7):1709-16. doi:10.2337/dc06-1549.
35. Doar JW, Wilde CE, Thompson ME, et al. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus. Lancet. 1975;1(7919):1263-6.
36. Kelley DE, Wing R, Buonocore C, et al. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1993;77(5):1287-93. doi:10.1210/jcem.77.5.8077323.
37. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes. 2010;34(3):462-71. doi:10.1038/ijo.2009.254.
38. Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes. 2009;33(7):786-95. doi:10.1038/ijo.2009.79.
39. Valderas JP, Irribarra V, Rubio L, et al. Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects. Obes Surg. 2011;21(7):902-9. doi:10.1007/s11695-011-0375-4.
40. Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg. 2014;24(2):241-52. doi:10.1007/s11695-013-1066-0.
41. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36(1):20-6. doi:10.2337/dc12-0779.
42. Dixon JB, Hur KY, Lee WJ, et al. Gastric bypass in type 2 diabetes with BMI<30: weight and weight loss have a major influence on outcomes. Diabet Med: J B Diabet Assoc. 2013;30(4):e127-34. doi:10.1111/dme.12107.
43. Kim JW, Cheong JH, Hyung WJ, et al. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol: WJG. 2012;18(1):49-54. doi:10.3748/wjg.v18.i1.49.
44. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA: J Am Med Assoc. 2008;299(3):316-23. doi:10.1001/jama.299.3.316.
45. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147(5):664-9. doi:10.1016/j.surg.2009.10.059.